New GMP database launched by EMEA

13 May 2007

A new database, designed to facilitate the exchange of information on compliance with Good Manufacturing Practice within the European network - called EudraGMP - has been introduced by the European Medicines Agency (EMEA). The Agency claims this will enhance the ability of national competent authorities in Europe to supervise the quality of medicines.

EudraGMP contains information on all manufacturing and importation authorizations issued by national competent authorities within the network, ie, the European Union's member states plus Iceland, Liechtenstein and Norway, and will contain data on GMP certifications. With around 15,000 importers and manufacturers in the countries concerned, the EMEA says it is expected that data from up to 7,000 new GMP certificates will be included in the database each year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight